BACKGROUND It is uncertain whether a diagnostic strategy supplemented by early coronary computed tomography
A cute chest pain can herald severe cardiovascular conditions, such as an acute coronary syndrome (ACS) (1) . However, the differential diagnosis of acute chest pain is broad, and the consequences of misdiagnosis can be detrimental (2) (3) (4) .
Physicians confront this diagnostic dilemma daily.
Coronary computed tomography angiography (CCTA) allows noninvasive visualization of the coronary arteries (5) . Because of its high accuracy in ruling out coronary artery disease (CAD), CCTA has been proposed for better decision making in the emergency department (ED), allowing for rapid discharge of patients without important CAD and, possibly, more appropriate referral for coronary revascularization (6, 7) .
Early CCTA as a diagnostic strategy in low-to intermediate-risk patients suspected of ACS is considered safe and may provide logistic and economic benefits (8) (9) (10) . Meanwhile, high-sensitivity troponin assays (hs-troponins) have become standard practice in many institutions, allowing for more accurate and faster rule-out of ACS (11, 12) . Whether hs-troponins RANDOMIZATION. Trial participants were randomly assigned to a CCTA-based diagnostic strategy or SOC (1:1). For allocation, a computer-generated block randomization sequence was used, stratified by participating center.
An independent physician at the coordinating center extracted the randomization schedule from an electronic randomization tool and codes were sent in sealed, sequentially numbered, opaque envelopes to the participating centers.
PROCEDURES. The initial standard clinical work-up at the ED included a 12-lead electrocardiogram (ECG) and blood analysis. If the initial clinical work-up did not reveal either an evident ACS or an evident noncardiac cause, eligible and consenting patients were randomized between a CCTA-guided strategy and SOC. In the intervention group, CCTA was performed after the initial clinical work-up at the ED. In both groups, hs-troponins were available (Online Table 1 ). Image acquisition was performed on 64-slice or a more advanced computed tomography (CT) system, using ECG-synchronized axial or spiral scan protocols combined with radiation minimizing measures, depending on local practices, available technology, and patient characteristics. Results of CCTA were reported by certified radiologists with a minimum of 2 years of experience reading CCTA.
Treating physicians were informed directly at the point of care regarding the result of CCTA and imaging-based recommendations were issued. Final medical management decisions were, however, left to the treating physicians ( Figure 1 ). In the SOC group, CT Angiography for Triage of Suspected ACS (13, 14) . Participants from both groups who were discharged from the ED, without prolonged observation (<8 h) were asked to return to the outpatient clinic after 48 to 72 h for repeated measurement of cardiac biomarkers and a 12-lead ECG. All participants were followed-up at the outpatient clinic or contacted by telephone after 30 days. Table 3 ). The median length of stay was similar in both groups. ExECG was the most commonly performed alternative noninvasive diagnostic test. In the CCTA group, 32 (13%) patients underwent ExECG within 30 days: 3 (9%) were suspected of ischemia and 10 (31%) were nondiagnostic.
In the SOC group, 143 (58%) patients underwent ExECG within 30 days: 9 (6%) were suspected of ischemia and 39 (27%) were nondiagnostic (Online Table 2 ). Outpatient testing was less frequently per- Values are mean AE SD, n (%), or median (interquartile range). Diabetes mellitus is defined as plasma glucose >11.0 mmol/l or treated with either diet regulation or medication. Ischemic ECG abnormalities are defined as Q-wave or ST-T-segment alterations suggestive of ischemia. *Elevated within 3 times the upper limit of the 99th percentile.
Shortly after these initial studies, randomized controlled trials were initiated to examine whether a CCTA-based strategy would be more clinically effec- A diagnostic strategy supplemented by early CCTA was inclined to detect more patients with significant CAD requiring coronary revascularization in our study; however, this was not of statistical significance. The results of our logistic endpoints differ from previous trials, as early performance of CCTA did not shorten the length of stay, nor reduce the number of hospital admissions in our study. The length of stay with early CCTA in this study is comparable or even lower than previously reported ( Figure 3) . However, the length of stay in our SOC group was substantially lower (median 6.3 h), underlining the vigorous improvement of SOC after the introduction of hs-troponins, and also making it harder to achieve an improvement with early CCTA. Values are median (interquartile range) or n (%). *Total of ExECG, SPECT, CMR, and CCTA in an outpatient setting after index ED visit.
CMR ¼ cardiac magnetic resonance imaging; ExECG ¼ exercise electrocardiography; SPECT ¼ single-photon emission computed tomography myocardial perfusion imaging; other abbreviations as in Table 1 . Invasive coronary angiography at index visit 34 (14) 25 (10) 0.21
Coronary revascularization* 22 (9) 17 (7) 0.40
Percutaneous coronary intervention 22 (9) 13 (5) Coronary artery bypass graft surgery 0 4 (2)
Acute coronary syndrome at discharge 22 (9) 17 (7) 0.40
Myocardial infarction 14 (6) 14 (6) Repeat emergency department visit 13 (5) 19 (8) avoids overcrowding and likely increased the overall coronary disease prevalence in our population (25, 26) . Furthermore, coverage by Dutch insurance companies is comparable for elective and emergency care, and financial incentives that stimulate outpatient work-up and testing are in place (27, 28) . In the United States, delays in access to care, social differences, and insurance coverage problems increase the number of patients seeking care in the ED (29, 30) . In addition, although guidelines allow for outpatient testing in 48 to 72 h after discharge from the ED, U.S. physicians are more inclined to achieve a conclusive work-up for the presence of CAD before discharge because of the availability of the testing, poor follow-up, and vulnerability to litigation (31) (32) (33) (34) .
Testing is typically available only during working hours, leading to prolonged hospital stays. Nonetheless, we believe that the contrasting findings are largely explained by the profound effect of the introduction of hs-troponins in the work-up of suspected ACS (11, 12, 35 ).
An attractive consequence of early CCTA in our study was the reduced number of subsequent outpatient testing and lower medical costs at 30 days.
Outpatient testing was mostly driven by the preference of the treating physician to assess the presence of CAD as the cause of symptoms, which was no longer necessary if CCTA had been performed at first presentation. Although direct comparison of absolute costs between studies is difficult, the shorter length of stay, more frequent use of exercise testing instead of nuclear imaging, and relatively lower cost of CCTA likely reduced general medical expenditure in this study (36) . When comparing costs between the 2 groups in our study, some important aspects should be taken into account. According to the applied hospital cost-accounting system, CCTA was only slightly more expensive than ExECG. Nuclear myocardial imaging, which is substantially more costly than either CCTA or and clinical outcome has yet to be determined.
Although the majority of patients were evaluated with hs-troponins, 21% entered the study when these assays
were not yet available at a number of centers. 
